SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.860
-0.010 (-0.26%)
Apr 2, 2026, 3:08 PM EDT - Market open
SAB Biotherapeutics Employees
SAB Biotherapeutics had 86 employees as of December 31, 2025. The number of employees increased by 23 or 36.51% compared to the previous year.
Employees
86
Change (1Y)
23
Growth (1Y)
36.51%
Revenue / Employee
n/a
Profits / Employee
$49,550
Market Cap
271.26M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 23 | 36.51% |
| Dec 31, 2024 | 63 | 6 | 10.53% |
| Dec 31, 2023 | 57 | 1 | 1.79% |
| Dec 31, 2022 | 56 | -83 | -59.71% |
| Mar 31, 2022 | 148 | 62 | 72.09% |
| Dec 31, 2021 | 139 | 53 | 61.63% |
| Sep 30, 2021 | 143 | 57 | 66.28% |
| Jun 30, 2021 | 137 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Coherus Oncology | 147 |
| AC Immune | 122 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Prelude Therapeutics | 79 |
| Protara Therapeutics | 46 |
| ALX Oncology Holdings | 43 |
SABS News
- 13 days ago - SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 15 days ago - SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 15 days ago - SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 23 days ago - SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes - GlobeNewsWire
- 23 days ago - SAB BIO Reports Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
- 4 weeks ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director - GlobeNewsWire
- 3 months ago - SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire